651511000001103: Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)
\UK product\Virtual medicinal product\Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release effervescent oral tablet\Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)
\UK product\Virtual therapeutic moiety\Ranitidine\Product containing only ranitidine in oral dose form (medicinal product form)\Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release effervescent oral tablet\Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)
\UK product\Virtual therapeutic moiety\Ranitidine\Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release effervescent oral tablet\Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing histamine H2 receptor antagonist\Product containing ranitidine\Ranitidine\Product containing only ranitidine in oral dose form (medicinal product form)\Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release effervescent oral tablet\Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing histamine H2 receptor antagonist\Product containing ranitidine\Ranitidine\Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release effervescent oral tablet\Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing histamine receptor antagonist\Product containing histamine H2 receptor antagonist\Product containing ranitidine\Product containing ranitidine in oral dose form (medicinal product form)\Product containing only ranitidine in oral dose form (medicinal product form)\Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release effervescent oral tablet\Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing ranitidine in oral dose form (medicinal product form)\Product containing only ranitidine in oral dose form (medicinal product form)\Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release effervescent oral tablet\Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1865061000001111 Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1865071000001118 Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	Is a	Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release effervescent oral tablet	true	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) freeness indicator	Sugar free	false	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	VMP non-availability indicator	Not available	true	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	Has active ingredient	Ranitidine hydrochloride	false	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	Has active ingredient	Ranitidine	false	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	VMP non-availability indicator	Available	false	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Ranitidine	true	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	Has specific active ingredient	Ranitidine hydrochloride	true	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	Has dispensed dose form	Effervescent tablet	false	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	Has basis of strength substance	Ranitidine	true	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	Has dispensed dose form	Conventional release effervescent oral tablet	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets	Is pack of	False	Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier
Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd) 30 tablet 2 x 15 tablets	Has AMP	True	Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1865061000001111	Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1865071000001118	Ranitidine 300mg effervescent tablets (Kent Pharma (UK) Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module